 |
InterVenn Biosciences
Last updated: October 18, 2024
Aldo Carrascoso - Co-Founder and CEO
USA | Funding: $278.1M (+)
Website: https://intervenn.bio/
InterVenn Biosciences combined the molecular-level resolution of mass spectrometry with the throughput of artificial intelligence to create a unique platform to discover new biomarkers, provide more effective treatments, design precision medicine trials, and pursue novel targets.
Website: https://intervenn.bio/
InterVenn Biosciences combined the molecular-level resolution of mass spectrometry with the throughput of artificial intelligence to create a unique platform to discover new biomarkers, provide more effective treatments, design precision medicine trials, and pursue novel targets.
